PUT - SPRINTER OPEN END - AMGEN | Market Closed - Deutsche Boerse AG 01:44:46 2024-06-28 pm EDT | ||
| 3.89 EUR | -1.52% |
|
| Current month | -15.43% | ||
| 1 month | -23.43% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 3.89 | -1.52% |
| 24-06-27 | 3.95 | +2.33% |
| 24-06-26 | 3.86 | +16.62% |
| 24-06-25 | 3.31 | -11.02% |
| 24-06-24 | 3.72 | -11.00% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 01:44 pm EDT
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VU1W0G |
| ISIN | DE000VU1W0G8 |
| Date issued | 2023-01-09 |
| Strike | 353.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 8.09 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.37 € |
|---|---|
| Lowest since issue | 2.81 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Certificates
- Certificat
